Growth Metrics

Volitionrx (VNRX) Accumulated Expenses (2018 - 2025)

Volitionrx filings provide 8 years of Accumulated Expenses readings, the most recent being $4.2 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 21.14% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 21.14% increase, with the full-year FY2025 number at $4.2 million, up 21.14% from a year prior.
  • Accumulated Expenses hit $4.2 million in Q4 2025 for Volitionrx, down from $4.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $4.6 million in Q3 2025 to a low of $2.7 million in Q1 2023.
  • Median Accumulated Expenses over the past 5 years was $3.5 million (2024), compared with a mean of $3.5 million.
  • Biggest five-year swings in Accumulated Expenses: dropped 24.98% in 2022 and later surged 36.78% in 2023.
  • Volitionrx's Accumulated Expenses stood at $3.8 million in 2021, then fell by 24.98% to $2.9 million in 2022, then skyrocketed by 36.78% to $3.9 million in 2023, then dropped by 11.5% to $3.5 million in 2024, then rose by 21.14% to $4.2 million in 2025.
  • The last three reported values for Accumulated Expenses were $4.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.